NEW YORK (GenomeWeb News) – Agilent Technologies today announced a deal with BioDiscovery allowing that firm's customers access to Agilent SureFISH probes directly from BioDiscovery's Nexus software.
The deal allows researchers who use different cytogenetic microarray platforms to now quickly identify aberrations with Nexus and to immediately identify and link to available oligonucleotide-based fluorescent in situ hybridization probes for follow-up studies, Agilent said.
Financial and other terms of the deal were not disclosed.
SureFISH probes are designed for specific, non-repetitive regions of the genome and allow scientists to detect repetitive and aberrant regions as small as 50 kb. The probes reduce the hybridization time to as little as four hours, Agilent said.
BioDiscovery's Nexus Copy Number software is for analysis and visualization of copy number variations from comparative genomic hybridization arrays, single-nucleotide polymorphism arrays, and next-generation sequencing data.